Odyssey Health (ODYY) Net Equity Issued and Repurchased (2020 - 2024)
Odyssey Health's (ODYY) quarterly Net Equity Issued and Repurchased came in at $9800.0 in Q1 2024, down 95.11% year-on-year from $200320.0 in Q1 2023, and down 78.61% quarter-over-quarter from $45820.0 in Q4 2023.
Odyssey Health (ODYY) Net Equity Issued and Repurchased (2020 - 2024) Analysis & Trends
Odyssey Health's Net Equity Issued and Repurchased history runs 5 years deep, the most recent figure standing at $9800.0 for Q1 2024.
- On a quarterly basis, Net Equity Issued and Repurchased fell 95.11% year-over-year to $9800.0 in Q1 2024; TTM through Oct 2024 was $9800.0, a 97.46% decrease from a year earlier, with the FY2024 full-year figure at $55620.0, down 90.41% from the prior year.
- Net Equity Issued and Repurchased fell to $9800.0 in Q1 2024 per ODYY's latest filing, from $45820.0 in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $2.4 million in Q2 2021 and bottomed at -$1.4 million in Q3 2022.
- The 5-year median for Net Equity Issued and Repurchased is $131690.0 (2023), against an average of $283483.2.
- Across the five-year window, Net Equity Issued and Repurchased jumped 246.81% in 2021 and tumbled 542.11% in 2022, its largest moves.
- Year by year, Net Equity Issued and Repurchased stood at $250000.0 in 2020, then soared by 246.81% to $867035.0 in 2021, then sank by 72.24% to $240710.0 in 2022, then plunged by 80.96% to $45820.0 in 2023, then slumped by 78.61% to $9800.0 in 2024.
- Per Business Quant, the three latest ODYY Net Equity Issued and Repurchased figures stand at $9800.0 (Q1 2024), $45820.0 (Q4 2023), and $7500.0 (Q3 2023).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 97.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 12.70 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Odyssey Health | 1.08 Mn | 782,508.17 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2024 | 9,800.00 |
| Jan 31, 2024 | 9,800.00 |
| Oct 31, 2023 | 45,820.00 |
| Oct 31, 2023 | 45,820.00 |
| Jul 31, 2023 | 7,500.00 |
| Jul 31, 2023 | 7,500.00 |
| Apr 30, 2023 | 131,690.00 |
| Apr 30, 2023 | 131,690.00 |
| Jan 31, 2023 | 200,320.00 |
| Jan 31, 2023 | 200,320.00 |
| Oct 31, 2022 | 240,710.00 |
| Oct 31, 2022 | 240,710.00 |
| Jul 31, 2022 | -1.39 Mn |
| Jul 31, 2022 | -1.39 Mn |
| Apr 30, 2022 | 1.10 Mn |
| Apr 30, 2022 | 1.10 Mn |
| Oct 31, 2021 | 867,035.00 |
| Oct 31, 2021 | 867,035.00 |
| Jul 31, 2021 | -216,753.00 |
| Jul 31, 2021 | -216,753.00 |